WO1996030395A3 - Cysteine protease inhibitor - Google Patents
Cysteine protease inhibitor Download PDFInfo
- Publication number
- WO1996030395A3 WO1996030395A3 PCT/JP1996/000840 JP9600840W WO9630395A3 WO 1996030395 A3 WO1996030395 A3 WO 1996030395A3 JP 9600840 W JP9600840 W JP 9600840W WO 9630395 A3 WO9630395 A3 WO 9630395A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- formula
- hydrogen atom
- amino acid
- cysteine protease
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/20—Esters of monothiocarboxylic acids
- C07C327/32—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/648,145 US6162828A (en) | 1995-03-31 | 1996-03-29 | Cysteine protease inhibitor |
AU51221/96A AU5122196A (en) | 1995-03-31 | 1996-03-29 | Cysteine protease inhibitor |
EP96907705A EP0820464A2 (en) | 1995-03-31 | 1996-03-29 | Cysteine protease inhibitor |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7/75594 | 1995-03-31 | ||
JP7/75593 | 1995-03-31 | ||
JP7559395 | 1995-03-31 | ||
JP7559495 | 1995-03-31 | ||
JP7/265723 | 1995-10-13 | ||
JP26572395 | 1995-10-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1996030395A2 WO1996030395A2 (en) | 1996-10-03 |
WO1996030395A3 true WO1996030395A3 (en) | 1996-12-27 |
Family
ID=27301885
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1996/000840 WO1996030395A2 (en) | 1995-03-31 | 1996-03-29 | Cysteine protease inhibitor |
Country Status (5)
Country | Link |
---|---|
US (1) | US6162828A (en) |
EP (1) | EP0820464A2 (en) |
AU (1) | AU5122196A (en) |
CA (1) | CA2215211A1 (en) |
WO (1) | WO1996030395A2 (en) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5744451A (en) * | 1995-09-12 | 1998-04-28 | Warner-Lambert Company | N-substituted glutamic acid derivatives with interleukin-1 β converting enzyme inhibitory activity |
HUP9700816A3 (en) * | 1997-04-28 | 1999-06-28 | Gyogyszerkutato Intezet | 3(r)-3-amino-4-carboxy-butiraldehyde derivatives inhibiting release of interleukin-1-beta |
EP1062210B1 (en) | 1998-03-09 | 2005-06-01 | Vertex Pharmaceuticals Incorporated | 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors |
PT1064298E (en) | 1998-03-19 | 2009-01-02 | Vertex Pharma | Inhibitors of caspases |
US6242422B1 (en) * | 1998-10-22 | 2001-06-05 | Idun Pharmacueticals, Inc. | (Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
US7157430B2 (en) | 1998-10-22 | 2007-01-02 | Idun Pharmaceuticals, Inc. | (Substituted)acyl dipeptidyl inhibitors of the ICE/CED-3 family of cysteine proteases |
JP4273662B2 (en) * | 1999-04-26 | 2009-06-03 | 味の素株式会社 | Melanocyte stimulating hormone inhibitor |
PA8507801A1 (en) | 1999-12-03 | 2002-08-26 | Agouron Pharma | ANTIPICORNAVIRAL COMPOUNDS AND COMPOSITIONS, THEIR PHARMACEUTICAL USES AND THE MATERIALS FOR SYNTHESIS |
SK13922002A3 (en) | 2000-03-29 | 2003-09-11 | Vertex Pharmaceuticals Incorporated | Carbamate caspase inhibitors and uses thereof |
PA8515201A1 (en) * | 2000-04-14 | 2002-10-24 | Agouron Pharma | ANTIPICORNAVIRAL COMPOUNDS AND COMPOSITIONS; YOUR PHARMACEUTICAL USES AND MATERIALS FOR SYNTHESIS |
US6525024B1 (en) | 2000-04-17 | 2003-02-25 | Idun Pharmaceuticals, Inc. | Inhibitors of the ICE/ced-3 family of cysteine proteases |
PE20011350A1 (en) | 2000-05-19 | 2002-01-15 | Vertex Pharma | PROPHARMAC OF AN INHIBITOR OF INTERLEUKIN-1ß CONVERTER ENZYME (ICE) |
CA2412618A1 (en) | 2000-06-14 | 2001-12-20 | Agouron Pharmaceuticals, Inc. | Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
EP1315971A2 (en) * | 2000-07-31 | 2003-06-04 | The Regents of The University of California | Model for alzheimer's disease and other neurodegenerative diseases |
US20020052323A1 (en) * | 2000-08-30 | 2002-05-02 | Jinhai Wang | Quinoline-(C=O)-(multiple amino acids)-leaving group compounds for pharmaceutical compositions and reagents |
US6777443B2 (en) * | 2001-05-15 | 2004-08-17 | Novartis Ag | Dipeptide derivatives |
US7153822B2 (en) * | 2002-01-29 | 2006-12-26 | Wyeth | Compositions and methods for modulating connexin hemichannels |
US20040052928A1 (en) * | 2002-09-06 | 2004-03-18 | Ehud Gazit | Peptides and methods using same for diagnosing and treating amyloid-associated diseases |
US7781396B2 (en) * | 2002-01-31 | 2010-08-24 | Tel Aviv University Future Technology Development L.P. | Peptides directed for diagnosis and treatment of amyloid-associated disease |
US7491699B2 (en) * | 2002-12-09 | 2009-02-17 | Ramot At Tel Aviv University Ltd. | Peptide nanostructures and methods of generating and using the same |
WO2004060791A1 (en) | 2003-01-07 | 2004-07-22 | Ramot At Tel Aviv University Ltd. | Peptide nanostructures encapsulating a foreign material and method of manufacturing same |
US7176208B2 (en) | 2003-04-18 | 2007-02-13 | Enanta Pharmaceuticals, Inc. | Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors |
JP5137400B2 (en) | 2003-06-30 | 2013-02-06 | テル アヴィヴ ユニヴァーシティ フューチャー テクノロジー ディヴェロップメント エル.ピー. | Peptides for diagnosing and treating amyloid-related diseases, antibodies thereto, and methods of use thereof |
CA2540407A1 (en) * | 2003-09-25 | 2005-03-31 | Tel Aviv University Future Technology Development L.P. | Compositions and methods using same for treating amyloid-associated diseases |
AU2004275821A1 (en) * | 2003-09-25 | 2005-04-07 | Dmi Biosciences Inc. | Methods and products which utilize N-acyl-L-aspartic acid |
US7625707B2 (en) * | 2003-10-02 | 2009-12-01 | Ramot At Tel Aviv University Ltd. | Antibacterial agents and methods of identifying and utilizing same |
AU2005249503B2 (en) | 2003-11-10 | 2011-08-25 | Vertex Pharmaceuticals Incorporated | ICE inhibitors for the treatment of autoinflammatory diseases |
WO2006013552A2 (en) | 2004-08-02 | 2006-02-09 | Ramot At Tel Aviv University Ltd. | Articles of peptide nanostructures and method of forming the same |
US7732479B2 (en) * | 2004-08-19 | 2010-06-08 | Tel Aviv University Future Technology Development L.P. | Compositions for treating amyloid associated diseases |
US7786086B2 (en) | 2004-09-08 | 2010-08-31 | Ramot At Tel-Aviv University Ltd. | Peptide nanostructures containing end-capping modified peptides and methods of generating and using the same |
US10004828B2 (en) | 2005-10-11 | 2018-06-26 | Romat at Tel-Aviv University Ltd. | Self-assembled Fmoc-ff hydrogels |
US7879212B2 (en) * | 2005-11-03 | 2011-02-01 | Ramot At Tel-Aviv University Ltd. | Peptide nanostructure-coated electrodes |
JP3975226B2 (en) * | 2006-01-11 | 2007-09-12 | 生化学工業株式会社 | Cycloalkylcarbonylamino acid derivative and process for producing the same |
JP4047365B2 (en) * | 2006-01-11 | 2008-02-13 | 生化学工業株式会社 | Cycloalkanecarboxamide derivative and method for producing the same |
CA2636765C (en) * | 2006-01-11 | 2014-03-18 | Seikagaku Corporation | Cycloalkylcarbonylamino acid ester derivative and process for producing the same |
US20080227688A1 (en) * | 2007-03-13 | 2008-09-18 | Johnston Randal N | Inhibition of viral replication |
US8791235B2 (en) * | 2008-05-21 | 2014-07-29 | Novagenesis Foundation | Selective caspase inhibitors and uses thereof |
WO2010133000A1 (en) | 2009-05-21 | 2010-11-25 | New World Laboratories Inc. | Selective caspase inhibitors and uses thereof |
GB201001070D0 (en) | 2010-01-22 | 2010-03-10 | St George's Hospital Medical School | Theraputic compounds and their use |
GB201011411D0 (en) | 2010-07-06 | 2010-08-18 | St Georges Hosp Medical School | Therapeutic compounds and their use |
WO2012061785A2 (en) | 2010-11-05 | 2012-05-10 | Brandeis University | Ice inhibiting compounds and uses thereof |
US9944674B2 (en) | 2011-04-15 | 2018-04-17 | Genesis Technologies Limited | Selective cysteine protease inhibitors and uses thereof |
US9956260B1 (en) | 2011-07-22 | 2018-05-01 | The J. David Gladstone Institutes | Treatment of HIV-1 infection and AIDS |
JP2022538360A (en) * | 2019-07-01 | 2022-09-01 | ビーエーエスエフ ソシエタス・ヨーロピア | Peptide acetals to stabilize enzymes |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2411829A1 (en) * | 1977-12-15 | 1979-07-13 | Reckitt & Colmann Prod Ltd | DERIVATIVES OF TETRAPEPTIDES, THEIR METHODS OF OBTAINING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
EP0221019A2 (en) * | 1985-10-14 | 1987-05-06 | Nippon Zoki Pharmaceutical Co. Ltd. | Peptides |
WO1992022570A1 (en) * | 1991-06-14 | 1992-12-23 | Chiron Corporation | Inhibitors of picornavirus proteases |
WO1993009135A1 (en) * | 1991-11-04 | 1993-05-13 | Sandoz Ltd. | Peptides inhibiting il-1 beta release |
EP0618223A2 (en) * | 1993-03-08 | 1994-10-05 | Sandoz Ltd. | Peptides inhibiting interleukin 1-bêta release useful as antiinflammatory agents |
WO1995005192A1 (en) * | 1993-08-13 | 1995-02-23 | Merck & Co., Inc. | SUBSTITUTED KETONE DERIVATIVES AS INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
EP0644198A1 (en) * | 1993-06-03 | 1995-03-22 | Sterling Winthrop Inc. | Alpha-heteroaryloxymethyl ketones as interleukin-1beta converting enzyme inhibitors |
EP0644197A1 (en) * | 1993-06-04 | 1995-03-22 | Sterling Winthrop Inc. | Peptidic phosphinyloxymethyl ketones as interleukin-1beta-converting enzyme inhibitors |
WO1995033751A1 (en) * | 1994-06-08 | 1995-12-14 | Sanofi Winthrop, Inc. | Bicycling lactam inhibitor of interleukin-1-beta converting enzyme |
WO1995035308A1 (en) * | 1994-06-17 | 1995-12-28 | Vertex Pharmaceuticals Incorporated | INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2071674C (en) * | 1991-06-21 | 2003-08-19 | Kevin T. Chapman | Peptidyl derivatives as inhibitors of interleukin-1.beta. converting enzyme |
EP0533226A3 (en) * | 1991-08-16 | 1993-08-18 | Merck & Co. Inc. | Novel chromophore containing compounds |
US5278061A (en) * | 1991-08-16 | 1994-01-11 | Merck & Co., Inc. | Affinity chromatography matrix useful in purifying interleukin-1β converting enzyme |
DE69229252T2 (en) * | 1991-08-16 | 1999-12-16 | Merck & Co Inc | DNA encoding the interleukin-1B precursor converting enzyme |
AU2468392A (en) * | 1991-08-29 | 1993-04-05 | Cytel Corporation | Novel immunosuppressants |
KR100226296B1 (en) * | 1991-08-30 | 1999-10-15 | 디. 꼬쉬 | Interleukin 1(beta) protease and interleukin 1(beta) protease inhibitor |
EP0547699A1 (en) * | 1991-12-19 | 1993-06-23 | Merck & Co. Inc. | Peptidyl derivatives as inhibitors of interleukin-1B converting enzyme |
WO1993016710A1 (en) * | 1992-02-21 | 1993-09-02 | Merck & Co., Inc. | PEPTIDYL DERIVATIVES AS INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
DK0654041T3 (en) * | 1992-07-31 | 1998-10-26 | Pfizer | Peptidyl-4-amino-2,2-difluoro-3-oxo-1,6-hexanedioic acid derivatives as anti-inflammatory agents |
US5374623A (en) * | 1992-08-20 | 1994-12-20 | Prototek, Inc. | Cysteine protease inhibitors effective for in vivo use |
DK0603769T3 (en) * | 1992-12-25 | 1999-06-14 | Mitsubishi Chem Corp | Alpha-amino ketone derivatives |
TW494094B (en) * | 1993-04-29 | 2002-07-11 | Vertex Pharma | Peptide analogs as irreversible interleukin-1β protease inhibitors and pharmaceutical compositions comprising the same |
US5462939A (en) * | 1993-05-07 | 1995-10-31 | Sterling Winthrop Inc. | Peptidic ketones as interleukin-1β-converting enzyme inhibitors |
DK0628550T3 (en) * | 1993-06-08 | 1998-09-28 | Vertex Pharma | Pyridazine as interleukin-1 beta-converted enzyme inhibitors |
US5514778A (en) * | 1993-07-01 | 1996-05-07 | Eli Lilly And Company | Anti-picornaviral agents |
IL112759A0 (en) * | 1994-02-25 | 1995-05-26 | Khepri Pharmaceuticals Inc | Novel cysteine protease inhibitors |
JPH07242599A (en) * | 1994-03-02 | 1995-09-19 | Yoshimitsu Nagao | Interleukin-1-producing inhibitor |
NZ283876A (en) * | 1994-03-31 | 2001-03-30 | Vertex Pharma | Pyrimidinyl derivatives as interleukin inhibitors |
MX9605196A (en) * | 1994-04-29 | 1997-12-31 | Sanofi Winthrop Inc | HALOMETHYL AMIDES AS IL-1'beta' PROTEASE INHIBITORS. |
US5565430A (en) * | 1994-08-02 | 1996-10-15 | Sterling Winthrop Inc. | Azaaspartic acid analogs as interleukin-1β converting enzyme inhibitors |
-
1996
- 1996-03-29 CA CA002215211A patent/CA2215211A1/en not_active Abandoned
- 1996-03-29 AU AU51221/96A patent/AU5122196A/en not_active Abandoned
- 1996-03-29 US US08/648,145 patent/US6162828A/en not_active Expired - Fee Related
- 1996-03-29 WO PCT/JP1996/000840 patent/WO1996030395A2/en not_active Application Discontinuation
- 1996-03-29 EP EP96907705A patent/EP0820464A2/en not_active Withdrawn
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2411829A1 (en) * | 1977-12-15 | 1979-07-13 | Reckitt & Colmann Prod Ltd | DERIVATIVES OF TETRAPEPTIDES, THEIR METHODS OF OBTAINING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
EP0221019A2 (en) * | 1985-10-14 | 1987-05-06 | Nippon Zoki Pharmaceutical Co. Ltd. | Peptides |
WO1992022570A1 (en) * | 1991-06-14 | 1992-12-23 | Chiron Corporation | Inhibitors of picornavirus proteases |
WO1993009135A1 (en) * | 1991-11-04 | 1993-05-13 | Sandoz Ltd. | Peptides inhibiting il-1 beta release |
EP0618223A2 (en) * | 1993-03-08 | 1994-10-05 | Sandoz Ltd. | Peptides inhibiting interleukin 1-bêta release useful as antiinflammatory agents |
EP0644198A1 (en) * | 1993-06-03 | 1995-03-22 | Sterling Winthrop Inc. | Alpha-heteroaryloxymethyl ketones as interleukin-1beta converting enzyme inhibitors |
EP0644197A1 (en) * | 1993-06-04 | 1995-03-22 | Sterling Winthrop Inc. | Peptidic phosphinyloxymethyl ketones as interleukin-1beta-converting enzyme inhibitors |
WO1995005192A1 (en) * | 1993-08-13 | 1995-02-23 | Merck & Co., Inc. | SUBSTITUTED KETONE DERIVATIVES AS INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
WO1995033751A1 (en) * | 1994-06-08 | 1995-12-14 | Sanofi Winthrop, Inc. | Bicycling lactam inhibitor of interleukin-1-beta converting enzyme |
WO1995035308A1 (en) * | 1994-06-17 | 1995-12-28 | Vertex Pharmaceuticals Incorporated | INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
Non-Patent Citations (4)
Title |
---|
B.WEINSTEIN: "CHEMISTRY AND BIOCHEMISTRY OF AMINO ACIDS, PEPTIDES ANS PROTEINS", 1983, MARCEL DEKKER, NEW YORK, XP002017370 * |
BIOCHEM. J., vol. 296, no. 3, 1993, pages 601 - 605 * |
CHEMICAL ABSTRACTS, vol. 120, no. 5, 31 January 1994, Columbus, Ohio, US; abstract no. 48746w, P.J.SAVORY E.A.: "Reaction of proteasomes with peptidylchloromethanes and peptidyldiazomethanes" page 414; column 1; XP002017195 * |
R.E.DOLLE E.A.: "P1 aspartate-based peptide alpha-((2,6-dichlorobenzoyl)- oxy)methyl ketones as potent time-dependent inhibitors of ICE", JOURNAL OF MEDICINAL CHEMISTRY, vol. 37, 1994, WASHINGTON US, pages 563 - 564, XP002017194 * |
Also Published As
Publication number | Publication date |
---|---|
US6162828A (en) | 2000-12-19 |
AU5122196A (en) | 1996-10-16 |
WO1996030395A2 (en) | 1996-10-03 |
CA2215211A1 (en) | 1996-10-03 |
EP0820464A2 (en) | 1998-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1996030395A3 (en) | Cysteine protease inhibitor | |
CA2140598A1 (en) | Prolineamide derivatives | |
RU93005332A (en) | DERIVATIVES 4,1-BENZOXAZEPINA, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT | |
IE801342L (en) | Peptides | |
EP0670309A4 (en) | Compound with prolyl endopeptidase inhibitor activity and pharmaceutical use thereof. | |
WO1996016079A3 (en) | Alpha-ketoamide derivatives as cathepsin l inhibitor | |
ATE20469T1 (en) | CARBOXYALKYL DIPEPTIDES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICALS CONTAINING THEM. | |
AU666801B2 (en) | New peptide compounds derived from boronic acid, process for preparing them and pharmaceutical compositions containing them | |
IL110216A (en) | Valproic acid amide derivatives and pharmaceutical compositions containing them | |
WO1998004521B1 (en) | Potassium channel inhibitors | |
ES2119737T3 (en) | RETROVIRAL PROTEASE INHIBITOR COMPOUNDS. | |
HUT71482A (en) | 4,1-benzoxazepine derivatives, process for preparing them and pharmaceutical compositions containing them | |
MY109846A (en) | Dual inhibitors of no synthase and cyclooxygenase, process for their preparation and therapeutical compositions containing them | |
MY132251A (en) | Methods of inhibiting cell-cell adhesion | |
AU2251901A (en) | Methods and compounds for inhibiting MRP1 | |
GR3001441T3 (en) | Pyrrolidinylamide ester derivative having anti-prolyl endopeptidase activity, its synthesis and use and a pharmaceutical composition containing it | |
AU5553298A (en) | Method for protecting metal surfaces against corrosion in liquid or gaseous media | |
WO2001072263A3 (en) | Use of ectoin or ectoin derivatives for protecting stress proteins in the skin | |
WO2001091738A3 (en) | Naaladase inhibitors for treating amyotrophic lateral sclerosis | |
HUP9903459A2 (en) | Oxa- and tiabicyclo[3.1.0]hexane-carboxylic acids,compositions of the same | |
IL123802A0 (en) | Guanidino protease inhibitors | |
NZ510303A (en) | Hydroxamate-containing cysteine and serine protease inhibitors suitable for treatment of neurodegeneration, Alzheimer's, inflammation, cataracts, bone resorption, CNS injury | |
AU6602594A (en) | New phosphonic acid compounds, process for preparing them and pharmaceutical compositions containing them | |
CA2091144A1 (en) | Reaction product of nitrogen bases and phosphate esters as corrosion inhibitors | |
WO2003080631A3 (en) | Plasma carboxypeptidase b inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 08648145 Country of ref document: US |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AU AZ BB BG BR BY CA CN CZ EE GE HU IS KG KR KZ LK LR LT LV MD MG MK MN MX NO NZ PL RO RU SG SI SK TJ TM TR TT UA US UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref document number: 2215211 Country of ref document: CA Ref country code: CA Ref document number: 2215211 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1996907705 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1996907705 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1996907705 Country of ref document: EP |